Home › Heart Valve Diseases › Minnesota
Heart Valve Diseases clinical trials in Minnesota
8 studies for Heart Valve Diseases are looking for participants at sites in Minnesota.
Cities in Minnesota
EFS of the DUO System for Tricuspid Regurgitation
- Allina Health Minneapolis Heart Institute Foundation, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05913908CTSN Embolic Protection Trial
- Mayo Clinic, Rochester
Recruiting
Ages 60 and older · All sexes · Updated Sep 28, 2026 · NCT06027788Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
- Abbott Northwestern Hospital, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07321899Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Abbott Northwestern Hospital, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
- Minneapolis Heart Institute Foundation, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07516444The TRICURE EFS Study
- Minneapolis Heart Institute Foundation, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06506942A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease
- Mayo Clinic in Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07483203The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- CentraCare Heart and Vascular, Saint Cloud
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.